A Critical Look at HIV-Antibody Tests: 2. Benefits, Risks and Clinical Use.
Following their first article on HIV-antibody tests,(1) the authors, in this second article, on HIV-antibody testing focus on the benefits and risks that may result from use of the tests. The sequelae of testing, especially if the result is positive, often differ widely, depending on the person tested and on those around him/her. Significant social and psychiatric risks may outweigh any medical benefit of testing, especially for certain persons known to be at high risk of HIV infection. Accordingly, a detailed protocol is suggested for managing both patient requests and physician-perceived indications for HIV-antibody testing. The authors outline the preferred approach to obtaining informed consent, a prerequisite, in their opinion, for ordering the tests.
J W
JW
Frank
R A
RA
Coates
B J
BJ
Harvey
V
V
Goel
V
V
Schiralli
Can Fam Physician. 1987 May;33:1209-13
21263930
JAMA. 1985 Oct 18;254(15):2089-93
2995694
Postgrad Med. 1986 May 1;79(6):265-6, 268-70, 275-6
3703760
JAMA. 1986 Jul 18;256(3):346-7
3459898
JAMA. 1987 Feb 27;257(8):1046-7
3027424
Lancet. 1986 May 3;1(8488):1043
2871328
Lancet. 1987 May 23;1(8543):1164-8
2883489
Can Fam Physician. 1987 Sep;33:2005-11
21263971
Br Med J (Clin Res Ed). 1987 Jul 11;295(6590):73-4
3113641
JAMA. 1986 Apr 4;255(13):1706
3005677
JAMA. 1986 Oct 3;256(13):1768-74
3018307
Isr J Med Sci. 1986 Jul-Aug;22(7-8):524-8
3640749
Soc Sci Med. 1986;23(5):455-9
3639542
JAMA. 1987 Mar 13;257(10):1357-66
3546744